|
|
Office Locations:
|
6440 N. Swan Road, Suite 200
Tucson, AZ 85718
Phone: 520-748-4400
Fax: 520-748-0025
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 1987, Research Corporation Technologies in Tucson, Ariz., is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. The RCT BioVentures program is the vehicle through which RCT invests in start-up or early-stage companies with technologies that promise patented biomedical products with a clear competitive advantage. RCT has assets of more than $200 million to advance technology development through flexible, long-term investment options. The firm's initial financial commitment to its portfolio companies usually ranges from several hundred thousand dollars to several million dollars, and the firm reserves additional funds for the subsequent funding of successful companies. Within the United Kingdom and Australia, RCT BioVentures invests through Cambridge Research BioVentures Ltd. (CRB) and BioVentures Australia Pty. RCT launched CRB with Cambridge-based Emerging Technology Services Limited (ETS) in 2000 to support early development of promising biomedical and life sciences discoveries in the United Kingdom. Start-up Australia and RCT formed BioVentures Australia in March 1999 to invest in life science and medical technologies originating in Australia. Current interests include new life-sciences platforms, and preclinical and clinical-stage therapeutics, devices and diagnostics.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
